# TechMediaBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Rebrands as AI Maverick Intel to Focus on AI-Driven Engagement

Bionoid Pharma (OTC PINK: BINP)  has rebranded as AI Maverick Intel, Inc., signaling a strategic pivot toward artificial intelligence-powered customer acquisition and engagement solutions. The transformation follows the acquisition of AI Maverick Intel, a platform specializing in AI-based audience automation and intelligent two-way communication. The company aims to deploy its proprietary technology across healthcare, biotech, and other sectors to enhance targeting, engagement, and operational efficiency.

 To view the full press release, visit https://ibn.fm/YB9iO

 About Bionoid Pharma Inc.

 Bionoid Pharma Inc. is a forward-thinking company focused on leveraging artificial intelligence to unlock new commercial opportunities and improve digital engagement. With a strategic emphasis on growth through acquisitions, Bionoid’s five-year roadmap includes acquiring revenue-generating businesses and integrating its proprietary AI Maverick technology to enhance operational efficiency and user experience.

 AI Maverick is a versatile, AI-powered platform designed to support a wide range of applications, from intelligent customer interaction tools to dynamic communication and data-driven engagement systems. As Bionoid continues to evolve, the flexibility of the Maverick platform provides a foundation for innovation across multiple sectors. Through these initiatives, the company aims to build long-term value, attract strategic partners, and establish a strong position in the rapidly expanding AI ecosystem.

 For more information, visit the company’s website at: https://aimaverickintel.com/

 About TechMediaWire

 TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.TechMediaWire.com

 Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

 TechMediaWireAustin, Texaswww.TechMediaWire.com512.354.7000 OfficeEditor@TechMediaWire.com

 TechMediaWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/tmw/techmediabreaks-bionoid-pharma-inc-otc-pink-binp-rebrands-as-ai-maverick-intel-to-focus-on-ai-driven-engagement/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/bionoid-pharma-rebrands-as-ai-maverick-intel-inc-to-focus-on-ai-powered-customer-acquisition-solutions/2510a401b5196c0e3d178def1c744b1c) 

 



[Reddit Post](https://www.reddit.com/r/Business_NewsRamp/comments/1ko2vba/bionoid_pharma_rebrands_as_ai_maverick_intel_inc/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/255/16/echoXdm5.webp)